ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2901

Sputum Neutrophils from Individuals at-Risk for RA Demonstrate Increased Citrullinated Histone H3 Containing Neutrophil Extracellular Traps That Correlate with Sputum Anti-Cyclic Citrullinated Peptide Antibody Levels

Yuko Okamoto1, Nickie L. Seto2, Mariana J. Kaplan2, Ashley Visser1, Jill M. Norris3, Kevin D. Deane1, V. Michael Holers4 and M. Kristen Demoruelle1, 1Division of Rheumatology, University of Colorado Denver, Aurora, CO, 2Systemic Autoimmunity Branch, NIAMS/NIH, Bethesda, MD, 3Department of Epidemiology, Colorado School of Public Health, Aurora, CO, 4Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ACPA, Lung and rheumatoid arthritis (RA), NETosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, October 24, 2018

Title: 6W009 ACR Abstract: RA–Etiology & Pathogenesis II (2898–2903)

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Our group previously demonstrated that anti-citrullinated (cit) protein antibodies (ACPA) in the sputum correlate with remnants of neutrophil extracellular traps (NETs) in RA-free subjects At-Risk for future RA. Sputum neutrophils from these subjects also had increased ex vivo NET formation (NETosis) (Okamoto ACR 2017). However, it is unknown what specific features these sputum NETs contain and how they relate to inflammation and ACPA production in the lung. Of note, NETs variably contain cit proteins that can be targets of ACPA. Herein, we explored associations between ACPA and cit-histone H3 (cit-H3) in sputum NETs and local cytokines in the lung.

Methods: In 32 At-Risk subjects without synovitis yet At-Risk for RA because they were first-degree relatives (FDR) of RA patients (N=29) or serum ACPA(+) [N=13, 5/13 also FDRs] and in 16 serum ACPA(-) non-FDR healthy controls, we tested serum and induced sputum for ACPA using anti-cyclic cit peptide (CCP) ELISA (CCP3.1 IgG/IgA, Inova). After incubation of sputum plugs for 1 hour without stimulation followed by staining with Hoechst 33342, anti-myeloperoxidase (MPO) and anti-cit-H3, we determined sputum neutrophils that had formed NETs ex vivo by microscopy. Separately, in sputum cell-free supernatant, the level of NET remnants was quantified by sandwich ELISA for the NET-specific protein complex DNA-cit-H3, and the levels of IL-1β, IL-4, IL-6, IL-8, IL-10, TNFα and IFNγ were measured by Meso Scale Discovery assay.

Results: The % of sputum neutrophils that formed NETs was higher in serum CCP(+) At-Risk but not serum CCP(-) At-Risk subjects compared to controls (Figure 1A). However, the % of sputum neutrophils that formed NETs specifically expressing cit-H3 was higher in all At-Risk subjects (Figure 1B). In all At-Risk subjects, sputum anti-CCP levels significantly correlated with formation of cit-H3 containing NETs (Figure 1C) but not overall sputum NETosis. NET remnants containing DNA-Cit-H3 complexes also significantly correlated with sputum anti-CCP level (r=0.80, p<0.001). After accounting for multiple comparisons, sputum anti-CCP and DNA-cit-H3 levels significantly correlated with sputum levels of IL-6, IL-8, IL-10 and TNFα (Figure 2).

 

Conclusion: Sputum neutrophils in At-Risk subjects demonstrate increased cit-H3 expressing NETs that strongly correlate with sputum anti-CCP and multiple cytokines. These findings suggest that cit-H3-expressing NETosis in the lung may play a role in the development of ACPA. Additional studies are needed to determine associations with transitions to systemic ACPA and classified RA.


Disclosure: Y. Okamoto, None; N. L. Seto, None; M. J. Kaplan, None; A. Visser, None; J. M. Norris, None; K. D. Deane, Janssen, 2; V. M. Holers, None; M. K. Demoruelle, None.

To cite this abstract in AMA style:

Okamoto Y, Seto NL, Kaplan MJ, Visser A, Norris JM, Deane KD, Holers VM, Demoruelle MK. Sputum Neutrophils from Individuals at-Risk for RA Demonstrate Increased Citrullinated Histone H3 Containing Neutrophil Extracellular Traps That Correlate with Sputum Anti-Cyclic Citrullinated Peptide Antibody Levels [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/sputum-neutrophils-from-individuals-at-risk-for-ra-demonstrate-increased-citrullinated-histone-h3-containing-neutrophil-extracellular-traps-that-correlate-with-sputum-anti-cyclic-citrullinated-peptide/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sputum-neutrophils-from-individuals-at-risk-for-ra-demonstrate-increased-citrullinated-histone-h3-containing-neutrophil-extracellular-traps-that-correlate-with-sputum-anti-cyclic-citrullinated-peptide/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology